for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Jurnals are published.
Already have an account? Sign In to see the journals you follow.
Journal Cover   The Tan Sheet
  [0 followers]  Follow
    
   Full-text available via subscription Subscription journal
   ISSN (Print) 1530-1206
   Published by Informa plc Homepage  [15 journals]
  • Mylan Shareholders OK Tender As Perrigo Draws Irish Regulators’
           Rebuke
    • Abstract: Rx generics and specialty products manufacturer Mylan receives approval of two-thirds of votes cast at a shareholder meeting to tender an offer directly to Perrigo shareholders. Market analysts doubted Mylan’s chances with its shareholders and remain pessimistic about the tender for Perrigo.
      PubDate: Mon, 31 Aug 2015 00:05:00 -040
       
  • Foreign Firms’ Supplement GMP Problems Rival US Warnings
    • Abstract: One firm was on FDA’s import alert due to supplement GMP problems at the end of 2014, but more firms in 2015 “have been demonstrated to be non-compliant … to the point that we want to prevent the products from entering the US market,” according to the agency
      PubDate: Fri, 28 Aug 2015 18:25:02 -040
       
  • ‘Fitness Continuum’ Moves Consumers From Weight Loss To Sports
           Nutrition Segments
    • Abstract: A Dupont Nutrition & Health global survey identifies a “food and fitness continuum” of consumers transitioning from using weight loss products to sports nutrition. Dupont identifies consumers on the continuum as “motivated strugglers,” “enlightened actives” or “personal record performers.”
      PubDate: Fri, 28 Aug 2015 00:00:00 -040
       
  • FTC Pyramid Scheme Investigation Brings Energy Drink Direct Seller To
           Standstill
    • Abstract: FTC shuts down Vemma Nutrition on allegations of targeting college students and other young consumers in a pyramid scheme. The agency’s complaint in federal court follows consumer advocate Truth In Advertising’s two-year investigation of Vemma.
      PubDate: Thu, 27 Aug 2015 00:05:00 -040
       
  • Executive Decisions Roundup: E-hydrate, AHPA, EAS Consulting
    • Abstract: E-hydrate adds marketing, sales chiefs; Bennett directs AHPA membership development; Crane moves up at EAS; Youlab appoints Gutman; Beckham to Roar for drink line; and more news in brief.
      PubDate: Thu, 27 Aug 2015 00:00:04 -040
       
  • Mylan Floats Options To Control Perrigo As A Subsidiary, Delist Its Shares
    • Abstract: Perrigo’s latest appeal for shareholders to reject a potential offer noted Mylan would delist Perrigo shares. Mylan says it “remains fully confident” more than 80% of Perrigo ordinary shares would vote to accept a takeover offer, but it is “fully committed and prepared to operate Perrigo as a controlled subsidiary.”
      PubDate: Wed, 26 Aug 2015 00:05:08 -040
       
  • AREDS-Related Study Challenges Omega-3 Cognitive Benefit Claims
    • Abstract: Omega-3 supplementation had no impact on cognitive function in a five-year assessment of elderly people participating in AREDS2 research, say NIH researchers. But they add in the JAMA study that longer-term use of omega-3s could result in a different outcome.
      PubDate: Wed, 26 Aug 2015 00:05:01 -040
       
  • Industry Roundup: J&J Trims Splenda,
           MusclePharm Slims Down
    • Abstract: Splenda in J&J’s past; and MusclePharm slims down in restructuring.
      PubDate: Wed, 26 Aug 2015 00:00:00 -040
       
  • Canada Targets Banning Microbeads In Personal Care Products
    • Abstract: Canadian manufacturers, importers and exporters of microbead-containing personal care products have until Oct. 15 to submit information to Environment Canada on their operations under an initiative to regulate the ingredients' use. The department says it intends to align regulatory efforts with the U.S.
      PubDate: Tue, 25 Aug 2015 00:05:01 -040
       
  • ‘Natural’ Trendy In Toothpaste, But Purchase Standards Are
           Efficacy, Price
    • Abstract: Natural toothpaste marketers expect growing popularity of their products given recent reports over controversial ingredients in mainstream brands, however a branding consultant says consumers still are more swayed by efficacy and cost than whether a product is natural.
      PubDate: Tue, 25 Aug 2015 00:05:00 -040
       
  • Weekly Trademark Review Aug. 18, 2015
    • Abstract: OTC drug, personal care product and nutritional supplement trademark filings compiled by “The Tan Sheet” from Official Gazette of the U.S. Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps; and Class 5 – Pharmaceuticals.
      PubDate: Mon, 24 Aug 2015 12:10:00 -040
       
  • FTC Suggests FDA Scrap Current Homeopathic Regulatory Framework
    • Abstract: In comments on FDA’s homeopathic product regulation, FTC puts in writing what its officials have said about conflicts between its policy for regulating ad claims and FDA’s oversight of homeopathics manufacturing and marketing.
      PubDate: Mon, 24 Aug 2015 00:06:00 -040
       
  • FDA Warning Letter Roundup: DMBA, Herbals
    • Abstract: New Dawn Nutrition warned on DMBA products; and Prime Health makes drug claims online.
      PubDate: Mon, 24 Aug 2015 00:04:00 -040
       
  • FDA Recalls For Aug. 12-19
    • Abstract: Recalls reported by FDA for OTC drugs, nutritionals and personal care products.
      PubDate: Mon, 24 Aug 2015 00:03:44 -040
       
  • Vascepa Off-Label Communications Package Evolved With
           Lawsuit
    • Abstract: With the off-label promotion floodgates creaking open, NDA sponsors could begin to have more back and forths with FDA in court. A chart details proposals and counter-proposals from Amarin and FDA that led to final set of statements, materials and disclosures approved by the court.
      PubDate: Mon, 24 Aug 2015 00:03:32 -040
       
  • Limited Relief To Patent Owners In IPR Cases From PTO Proposed Rule
    • Abstract: In inter partes reviews by the Patent Trial and Appeal Board, patent owners would be able to provide expert testimony before a trial is instituted; however, the Patent and Trademark Office largely retains "broadest reasonable interpretation" standard for determining patent claims.
      PubDate: Mon, 24 Aug 2015 00:03:23 -040
       
  • Local Microbead Laws Emerge As Potential Threat To National Uniformity
    • Abstract: If a state patchwork of microbead laws weren't enough, counties in New York are eyeing bans on personal care products containing microbeads, with Erie County the first to pass local legislation in case the state or federal government fails to advance environmental protective measures. California is approaching the finish line with microbeads legislation that limits replacement options for personal care manufacturers.
      PubDate: Mon, 24 Aug 2015 00:03:00 -040
       
  • Oral Care Brands’ Social Media Fame Is Fuzzy Picture Of Sales Growth
    • Abstract: Hello Products is the most popular oral care brand on Instagram and Tom’s of Maine is analyzing how to improve its presence on the burgeoning social media site, but a branding consultant questions whether consumer product firms generate returns on their investment in social media.
      PubDate: Fri, 21 Aug 2015 00:05:00 -040
       
  • Arthri-D3 Name Remains After Testimonials Vanish
           During NAD Review
    • Abstract: NAD attorneys agree with CRN that the Arthri-D3 brand, when used in conjunction with testimonials related to relief from arthritis pain, “might convey the misleading message that Arthri-D3 immediately and completely relieves arthritis pain.” However, Arthri-D LLC discontinues the challenged testimonials.
      PubDate: Fri, 21 Aug 2015 00:00:05 -040
       
  • Amarin Decision Could Spur Pressure Against FDA Supplement Claim Policy
    • Abstract: First Amendment advocate Jonathan Emord says the industry bows to FDA “intimidation” in not making truthful claims for their products. But the federal district court ruling for Amarin is the latest decision to strike against FDA’s policy on regulating supplement label claims, he says.
      PubDate: Thu, 20 Aug 2015 00:00:05 -040
       
  • Products Imported As Supplements Contain Anticonvulsants, Cholesterol
           Drugs
    • Abstract: A July 15 import alert states that FDA and U.S. Customs officials can detain without physical examination certain imports from 20 foreign firms, including 14 from China.
      PubDate: Wed, 19 Aug 2015 00:00:05 -040
       
  • NBTY Brand Mission Moves Into Personal Care Space
    • Abstract: NBTY purchases the Dr. Organic/Organic Doctor personal care line, continuing its focus on building its branded consumer business, especially internationally.
      PubDate: Tue, 18 Aug 2015 00:05:00 -040
       
  • Industry News: NBTY VP, Hi-Tech Buys LG Brands
    • Abstract: NBTY adds another Coca-Cola exec to its top management; Hi-Tech extends into sports nutrition with LG brands.
      PubDate: Tue, 18 Aug 2015 00:00:02 -040
       
  • Industry Roundup: FTC, FDA Enforcement, Mannatech CEO,
           Quell Distribution
    • Abstract: FTC commissioner questions enforcement; Mannatech adds CEO to Bala’s title; Quell wearable pain relief heads for stores; ED drug in ‘Herb Viagra’; and more news in brief.
      PubDate: Mon, 17 Aug 2015 00:05:46 -040
       
  • Support For Supplement Claims In NAD Reviews Varies From Scientific To
           Spiritual
    • Abstract: NAD conducted its reviews of Great Health Works’ Omega-XL and Inspired Nutrition’s Ultimate Bio-Fibrin ads in its work supported by the Council for Responsible Nutrition. Each firm said it would follow NAD’s recommendations, but aligning with findings could be a bigger challenge for Inspired Nutrition.
      PubDate: Thu, 13 Aug 2015 00:05:01 -040
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2015